CHEK2 and hepatocellular carcinoma: Recently, a study reported that RTN3 interacts with and activates CHK2 in a Ca2+‐dependent manner, mediates p53 phosphorylation at Ser392, and increases its subsequent nuclear localization, thereby inhibiting the proliferation of hepatocellular carcinoma cells.29